Sun Pharma asked to pay Rs 279 crore GST dues on Ranbaxy arbitration

The Directorate General of Goods and Services Tax Intelligence (DGGI) has asked Sun Pharmaceutical Industries to pay approximately Rs 279 crore in service tax dues to the government, sources told CNBC-TV18. The move is part of the government’s efforts to boost revenue collections. The Directorate General of GST intelligence claims that Sun Pharma is liable to pay service tax on payments it had mad…